In adults with atopic dermatitis, moisturizers with anti-inflammatory ingredients significantly improved skin hydration and ...

Against the backdrop of Music City’s biggest weekend, leading experts and frontline clinicians will gather in downtown Nashville, Tennessee, for one of dermatology’s most impactful educational events ...

A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

People allergic to garlic experience immune-related symptoms to allicin and similar compounds. Find guidance on navigating ...

Panelists discuss how an 18-month retrospective claims analysis evaluated ruxolitinib's real-world effectiveness in atopic ...

Day 7 reading, showing allergic contact dermatitis reactions on the left upper back and irritant contact dermatitis reactions to the over-the-counter product patches on the right lower back.

multi-target therapeutics for atopic dermatitis and other severe and common skin diseases (PRNewsfoto/Alphyn Biologics) Zabalafin Hydrogel offers the potential to be the first singular ...

highlighted research from the American Academy of Dermatology meeting and said his biggest takeaway from the meeting was that dermatologists are in “the decade of atopic dermatitis.” ...

Its lead product candidate, Zabalafin Hydrogel, is being developed as a topical treatment for atopic dermatitis (AD), the most common form of eczema. Zabalafin Hydrogel has demonstrated strong ...